Biota Pharmaceuticals Inc Share Price Nasdaq
Stocks
US6295191091
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Market Cap | 12Cr 10Cr 9.51Cr 8.64Cr 16Cr 1.09TCr 16Cr 114.6Cr 45Cr 573.29Cr 43Cr 42Cr 1.82TCr | P/E 2026 * |
-2.97x | P/E 2027 * | -0.56x |
|---|---|---|---|---|---|
| Enterprise Value | 12Cr 10Cr 9.51Cr 8.64Cr 16Cr 1.09TCr 16Cr 114.6Cr 45Cr 573.29Cr 43Cr 42Cr 1.82TCr | EV / Sales 2026 * |
0.97x | EV / Sales 2027 * | 49.2x |
| Free-Float |
98.52% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Biota Pharmaceuticals Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Steven Lo
CEO | Chief Executive Officer | 60 | 18/03/2024 |
Sean Tucker
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/03/2024 |
Jeroen Grasman
DFI | Director of Finance/CFO | - | 19/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
David Wheadon
BRD | Director/Board Member | 68 | 21/04/2021 |
William Watson
BRD | Director/Board Member | 76 | 04/08/2022 |
Elaine Heron
BRD | Director/Board Member | 79 | 01/01/2022 |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 12Cr 11Cr 9.77Cr 8.87Cr 17Cr 1.12TCr 17Cr 117.65Cr 46Cr 588.58Cr 45Cr 44Cr 1.86TCr | 23.5L 20.98L 19.35L 17.58L 32.98L 22Cr 33.49L 2.33Cr 91.83L 12Cr 88.21L 86.32L 37Cr |
| Net income | -4.72Cr -4.21Cr -3.89Cr -3.53Cr -6.62Cr -447.1Cr -6.73Cr -47Cr -18Cr -234.24Cr -18Cr -17Cr -742.06Cr | -22Cr -20Cr -18Cr -17Cr -31Cr -2.1TCr -32Cr -219.82Cr -87Cr -1.1TCr -83Cr -81Cr -3.48TCr |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
